📰 GlobeNewswire
★ ★ ★ ☆ ☆

NurExone Biologic Inc. Announces Third Quarter 2025 Financial Results and Provides Corporate Update

tech
NurExone Biologic Inc. Announces Third Quarter 2025 Financial Results and Provides Corporate Update

TORONTO and HAIFA, Israel, Nov. 28, 2025 (GLOBE NEWSWIRE) – NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”), a preclinical-stage biotechnology company pioneering exosome-based therapies for central nervous system in…

Číst původní článek

Zdroj: 📰 GlobeNewswire